FdaApplication
NDA 217569
Identifiers
- fda_app_no: NDA217569
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 2023-09-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VASOPRESSIN IN SODIUM CHLORIDE 0.9% | VASOPRESSIN | 20UNITS/100ML (0.2UNITS/ML) | SOLUTION;INTRAVENOUS |
| VASOPRESSIN IN SODIUM CHLORIDE 0.9% | VASOPRESSIN | 40UNITS/100ML (0.4UNITS/ML) | SOLUTION;INTRAVENOUS |
2 products